Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice

Brain Research

Volumn 792, Issue 2, 1998, Pages 253-262

  L'Hirondel, M ^a   Cheramy A ^a   Godeheu, G ^a   Artaud, F ^a   Saiardi, A ^b   Borrelli, E ^b   Glowinski, J ^a  

^a INSERM   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

D2 receptor deficient mice; Dopamine autoreceptors; Dopamine release; Striatum; Synaptosomes

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 4 AMINOPYRIDINE; AMPHETAMINE DERIVATIVE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; POTASSIUM; QUINPIROLE; VERATRIDINE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONCENTRATION RESPONSE; DOPAMINE RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SYNAPTOSOME;

4-AMINOPYRIDINE; AMPHETAMINE; ANIMALS; APOMORPHINE; AUTORECEPTORS; BENZOPYRANS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEINS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NEURAL INHIBITION; OXAZINES; POTASSIUM CHLORIDE; PRESYNAPTIC TERMINALS; QUINPIROLE; RECEPTORS, DOPAMINE D2; SYNAPTOSOMES; TRITIUM;

EID: 0032507729     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00146-2     Document Type: Article

References (60)

1. Accili D., Fishburn C.S., Drago J., Steiner H., Lachowicz J.E., Park B.H., Gauda E.B., Lee E.J., Cool M.H., Sibley D.R., Gerfen C.R., Westphal H., Fuchs S. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1945-1949.
2. Aghajanian G.K., Bunney B.S. Dopamine 'autoreceptors': pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 297:1977;1-7.
3. Aretha C.W., Sinha A., Galloway M.P. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors. J. Pharmacol. Exp. Ther. 274:1995;609-613.
4. A and D3 subtypes. Brain Res. 649:1994;95-110.
5. Ariano M.A., Stromski C.J., Smyk-Randall E.M., Sibley D.R. D2 dopamine receptor localization on striatonigral neurons. Neurosci. Lett. 144:1992;215-220.
6. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377:1995;424-428.
7. Besson M.J., Chéramy A., Feltz P., Glowinski J. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat. Brain Res. 32:1971;407-424.
8. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564:1991;203-219.
9. 3H]-dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists. J. Pharmacol. Exp. Ther. 241:1987;27-33.
10. Calabresi P., Saiardi A., Pisani A., Baik J.H., Centonze D., Mercuri N.B., Bernardi G., Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17:1997;4536-4544.
11. Cass W.A., Zahniser N.R. Inhibition of striatal dopamine release by the selective D2 dopamine receptor agonist N-0437 is blocked by quinine. Synapse. 5:1990;336-337.
12. Cass W.A., Zahniser N.R. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. J. Neurochem. 57:1991;147-152.
13. Chesselet M.F. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience. 12:1984;347-375.
14. 3H]-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors. Eur. J. Pharmacol. 56:1979;411-412.
15. Dawson V.L., Dawson T.M., Filloux F.M., Wamsley J.K. Evidence for dopamine D2 receptors on cholinergic interneurons in the rat caudate-putamen. Life Sci. 42:1988;1933-1939.
16. De Keyser J., Ebinger G. Neostriatal dopamine receptors. TINS. 13:1990;324-325.
17. Demotes Mainard J., Henry C., Jeantet Y., Arsaut J., Arnauld E. Postnatal ontogeny of dopamine D3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression. Brain Res. Dev. Brain Res. 94:1996;166-174.
18. Desce J.M., Godeheu G., Galli T., Glowinski J., Chéramy A. Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes. Brain Res. 640:1994;205-214.
19. Diaz J., Lévesque D., Lammers C.H., Griffon N., Martres M.P., Schwartz J.C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65:1995;731-745.
20. Diaz J., Ridray S., Mignon V., Griffon N., Schwartz J.C., Sokoloff P. Selective expression of dopamine D3 receptors mRNA in proliferative zones during embryonic development of the rat brain. J. Neurosci. 17:1997;4282-4292.
21. S.D. Dickinson, G.A. Larson, G.A. Gerhardt, M.A. Kelly, M. Rubinstein, D.K. Grandy, M.J. Low, N.R. Zahniser, Dopamine transporters in D2 dopamine receptor-deficient mice, Soc. Neurosci. Abstr. (1997) 693.7.
22. 1A dopamine receptors. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12564-12568.
23. Dunkley P.R., Heath J.W., Harrison S.M., Jarvie P.E., Glenfield P.J., Rostas J.P.A. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441:1988;59-71.
24. El Mestikawy S., Glowinski J., Hamon M. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals. J. Neurochem. 46:1986;12-22.
25. + induced depolarization and/or forskolin in rat striatal slices. J. Neurochem. 45:1985;173-184.
26. Fillenz M. Short-term control of transmitter synthesis in central catecholaminergic neurones. Prog. Biophys. Mol. Biol. 60:1993;29-46.
27. 3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals. Synapse. 2:1988;521-531.
28. 3H]sulpiride. Eur. J. Pharmacol. 138:1987;61-68.
29. A knockout mice. Mol. Pharmacol. 51:1997;6-11.
30. Gainetdinov R.R., Grekhova T.V., Sotnikova T.D., Rayevsky K.S. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur. J. Pharmacol. 261:1994;327-331.
31. Gobert A., Rivet J.M., Audinot V., Cistarelli L., Spedding M., Vian J., Peglion J.L. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and 'silent' D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol. Exp. Ther. 275:1995;899-913.
32. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. TINS. 18:1995;527-535.
33. Le Moine C., Bloch B. Rat striatal and mesencephalic neurons contain the long isoform of the D2 dopamine receptor mRNA. Brain Res. Mol. Brain Res. 10:1991;283-289.
34. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 388:1997;586-589.
35. Meador-Woodruff J.H., Damask S.P., Watson S.J. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8297-8301.
36. Meller E., Bohmaker K., Goldstein M., Basham D.A. Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors. Eur. J. Pharmacol. 249:1993;R5-R6.
37. Mercuri N.B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G., Borrelli E. Loss of autoreceptor function in dopaminergic neurons from dopaminergic D2 receptor deficient mice. Neuroscience. 79:1997;323-327.
38. Miner L.L., Drago J., Chamberlain P.M., Donovan D., Uhl G.R. Retained cocaine conditioned place preference in D1 receptor deficient mice. NeuroReport. 6:1995;2314-2316.
39. Moratalla R., Xu M., Tonegawa S., Graybiel A.M. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14928-14933.
40. Murray A.M., Ryoo H.L., Gurevich E., Joyce J.N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11271-11275.
41. Ogawa N. Molecular and chemical neuropharmacology of dopamine receptor subtypes. Acta Med. Okayama. 49:1995;1-11.
42. Onali P., Olianas M.C., Bunse B. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes. Brain Res. 456:1988;302-309.
43. Paulus M.P., Grandy D., Low M., Kelly M., Dulawa S.C., Geyer M.A. Assessment of behavioral organization differentially characterizes D2 and D4 knock out mice. Soc. Neurosci. Abstr. 68:1996;68.10.
44. Pinnock R.D. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra. Br. J. Pharmacol. 81:1984;631-635.
45. Pugsley T.A., Davis M.D., Akunne H.C., MacKenzie R.G., Shih Y.H., Damsma G. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD-128,907. J. Pharmacol. Exp. Ther. 275:1995;1355-1366.
46. Pugsley T.A., Whetzel S., Corbin A.E., VanLeeuwen D., MacKenzie R.G., Heffner T., Rubinstein M., Low M.J., Grandy D.K. Dopamine synthesis is increased in mice lacking dopamine D4 receptors. Soc. Neurosci. Abstr. 523:1996;523.10.
47. Raiteri M., Cervoni A.M., Del Carmine R. Do presynaptic autoreceptors control dopamine release. Nature. 274:1978;706-707.
48. Saiardi A., Samad A.T., Picetti R., Bozzi Y., Baik J.-H., Borrelli E. The physiological role of dopamine D2 receptors. Adv. Pharmacol. 42:1997;521-524.
49. Sautel F., Griffon N., Lévesque D., Pilon C., Schwartz J.C., Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. NeuroReport. 6:1995;329-332.
50. Scatton B. Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci. 31:1982;2883-2890.
51. Schoemaker H., Claustre Y., Fage D., Rouquier L., Chergui K., Curet O., Oblin A., Carter C., Benavides J., Scatton B. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J. Pharmacol. Exp. Ther. 280:1997;83-97.
52. Seeman P., Watanabe M., Grigoriadis D., Tedesco J.L., George S.R., Svensson U., Neumeyer J.L. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol. Pharmacol. 28:1985;391-399.
53. Sesack S.R., Aoki C., Pickel V.M. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14:1994;88-106.
54. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
55. Sokoloff P., Schwartz J.C. Novel dopamine receptors half a decade later. TIPS. 16:1995;270-275.
56. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69:1989;864-987.
57. Tang L., Todd R.D., O'Malley K.L. Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270:1994;475-479.
58. Tepper J.M., Sun B.C., Martin L.P., Creese I. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analysed by antisense knockdown in vivo. J. Neurosci. 17:1997;2519-2530.
59. 3H]-N-propylnorapomorphine. Eur. J. Pharmacol. 56:1979;291-292.
60. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.